These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Expression and prognostic value of hemopoietic cytokine receptors in acute myeloid leukemia (AML): implications for future therapeutical strategies. Graf M; Hecht K; Reif S; Pelka-Fleischer R; Pfister K; Schmetzer H Eur J Haematol; 2004 Feb; 72(2):89-106. PubMed ID: 14962246 [TBL] [Abstract][Full Text] [Related]
3. [Diagnostic value of some cytokines levels in chronic myelogenous leukemia]. Kiersnowska-Rogowska B; Parfieńczyk A; Rogowski F; Citko A; Jaroszewicz E Pol Merkur Lekarski; 2000 Mar; 8(45):129-32. PubMed ID: 10870415 [TBL] [Abstract][Full Text] [Related]
4. [Examination of interleukin levels and growth factor from blood platelets in leukemia]. Kiersnowska-Rogowska B; Rogowski F; Petelski T; Citko A; Jaroszewicz E; Bielawiec M Pol Tyg Lek; 1996 May; 51(19-22):281-2, 288. PubMed ID: 9289710 [TBL] [Abstract][Full Text] [Related]
5. [Effect of cytostatic therapy on IL-1beta and L-selectin concentrations, synthesis, accumulation and excretion in patients with acute myeloid leukaemia]. Kiersnowska-Rogowska B; Parfieńczyk A; Rogowski F Pol Merkur Lekarski; 2004 Oct; 17(100):341-4. PubMed ID: 15690697 [TBL] [Abstract][Full Text] [Related]
6. Implication of Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) and Interleukin-3 (IL-3) in Children with Acute Myeloid Leukaemia (AML); Malignancy. Elbaz O; Shaltout A Hematology; 2001; 5(5):383-388. PubMed ID: 11399637 [TBL] [Abstract][Full Text] [Related]
7. Relations between IL-3-induced proliferation and in vitro cytokine secretion of bone marrow cells from AML patients. Nowak R; Oelschlägel U; Gurth H; Range U; Albrecht S; Krebs U; Hietschold V; Ehninger G Cytokine; 1999 Jun; 11(6):435-42. PubMed ID: 10346983 [TBL] [Abstract][Full Text] [Related]
8. [Characteristics of T-cell immunity in patients with acute leukemia]. Parovichnikova EN; Gal'tseva IV; Vorob'ev IA; Savchenko VG Ter Arkh; 2006; 78(7):18-25. PubMed ID: 16944746 [TBL] [Abstract][Full Text] [Related]
9. Leukemia-derived dendritic cells can be generated from blood or bone marrow cells from patients with acute myeloid leukaemia: a methodological approach under serum-free culture conditions. Kufner S; Zitzelsberger H; Kroell T; Pelka-Fleischer R; Salem A; de Valle F; Schweiger C; Nuessler V; Schmid C; Kolb HJ; Schmetzer HM Scand J Immunol; 2005 Jul; 62(1):86-98. PubMed ID: 16091128 [TBL] [Abstract][Full Text] [Related]
10. Cytokine and adhesion molecule concentrations in blood of patients with B-cell chronic lymphocytic leukaemia with regard to disease progression. Parfieńczyk A; Kiersnowska-Rogowska B; Rogowski F Rocz Akad Med Bialymst; 2003; 48():90-4. PubMed ID: 14737950 [TBL] [Abstract][Full Text] [Related]
11. Intracellular IL-4, IL-10, and IFN-gamma levels of leukemic cells and bone marrow T cells in acute leukemia. Park HH; Kim M; Lee BH; Lim J; Kim Y; Lee EJ; Min WS; Kang CS; Kim WI; Shim SI; Han K Ann Clin Lab Sci; 2006; 36(1):7-15. PubMed ID: 16501231 [TBL] [Abstract][Full Text] [Related]
12. Systemic inflammatory response to exhaustive exercise. Cytokine kinetics. Suzuki K; Nakaji S; Yamada M; Totsuka M; Sato K; Sugawara K Exerc Immunol Rev; 2002; 8():6-48. PubMed ID: 12690937 [TBL] [Abstract][Full Text] [Related]
13. Glucocorticoid-induced tumor necrosis factor receptor-related protein ligand subverts immunosurveillance of acute myeloid leukemia in humans. Baessler T; Krusch M; Schmiedel BJ; Kloss M; Baltz KM; Wacker A; Schmetzer HM; Salih HR Cancer Res; 2009 Feb; 69(3):1037-45. PubMed ID: 19155305 [TBL] [Abstract][Full Text] [Related]
14. Differential modulation of immune recognition molecules by interleukin-7 in human acute leukaemias. Costello RT; Mallet F; Chambost H; Sainty D; Gastaut JA; Olive D Eur Cytokine Netw; 1999 Mar; 10(1):87-96. PubMed ID: 10210778 [TBL] [Abstract][Full Text] [Related]
15. Interleukin-12 production by leukemia-derived dendritic cells counteracts the inhibitory effect of leukemic microenvironment on T cells. Curti A; Pandolfi S; Aluigi M; Isidori A; Alessandrini I; Chiodoni C; Testoni N; Colombo MP; Baccarani M; Lemoli RM Exp Hematol; 2005 Dec; 33(12):1521-30. PubMed ID: 16338495 [TBL] [Abstract][Full Text] [Related]
16. Effect of arsenic trioxide on cytokine expression by acute promyelocytic leukemia cells. Jiang G; Bi K; Tang T; Zhang Y; Ren H; Jiang F; Ren Q; Zhen G; Liu C; Peng J; Guo G; Liu X; Tian Z Chin Med J (Engl); 2003 Nov; 116(11):1639-43. PubMed ID: 14642127 [TBL] [Abstract][Full Text] [Related]
17. IL-4, IL-10 and IL-13 in acute myelogenous leukemia. Bruserud O Cytokines Cell Mol Ther; 1998 Sep; 4(3):187-98. PubMed ID: 9825844 [TBL] [Abstract][Full Text] [Related]
18. Growth factors in acute myeloid leukaemia. Estey EH Best Pract Res Clin Haematol; 2001 Mar; 14(1):175-87. PubMed ID: 11355930 [TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor secretion is an independent prognostic factor for relapse-free survival in pediatric acute myeloid leukemia patients. de Bont ES; Fidler V; Meeuwsen T; Scherpen F; Hählen K; Kamps WA Clin Cancer Res; 2002 Sep; 8(9):2856-61. PubMed ID: 12231527 [TBL] [Abstract][Full Text] [Related]
20. Leptin in human acute myelogenous leukemia: studies of in vivo levels and in vitro effects on native functional leukemia blasts. Bruserud Ø; Huang TS; Glenjen N; Gjertsen BT; Foss B Haematologica; 2002 Jun; 87(6):584-95. PubMed ID: 12031914 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]